Genetic - Medika Life

Although rare by definition, the collective impact of rare diseases is anything but insignificant. In the Asia-Pacific (APAC) region – home to over half of...

Health Possibilities We Can’t Afford to Block

Gil Bashe, Medika Life Editor - November 15, 2022

Fixing one piece of the healthcare puzzle is encouraging - but is it transformational? Here are 10 things we can consider to make things better.

DNA, Dollars, and Dilemmas

John Nosta - July 12, 2022

Should advances in DNA sequencing go the way of Waze and credit cards?

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Diabetes Is a Major Risk Factor for Dementia. 115 Million Americans Have Prediabetes.

Health Innovation Has a Friction Problem

The Best Dating Game in Health Innovation Happens Just Off the Main Stage

Treating Rare Diseases: The Challenge of Access

LATEST

TRENDING

Alagille syndrome

Health Possibilities We Can’t Afford to Block

Lupus and its effects on women

The SERPINA1 Gene, serpin family A member 1

BRCA1 and 2: The Breast Cancer Genes

FBN1 gene, fibrillin 1

Marfan Syndrome (MFS)

Loeys-Dietz syndrome (LDS)

Crohn’s Disease. Symptoms, Diagnosis, and Treatment

Looking for Zebras: Medical Mysteries and Transformational Patient Moments

EDITORS CHOICE

Sudden Death, “Purebloods,” Myocarditis and more

Treating Rare Diseases: The Challenge of Access

Health Possibilities We Can’t Afford to Block

DNA, Dollars, and Dilemmas

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories